Updated:
Zhongqi Capital
Zhongqi Capital is a joint venture between Qidi Kefu and Sinochem's subsidiary. It focuses on fund investments in new materials, new energy, biotechnology, and...
Zhongqi Capital
Zhongqi Capital is a joint venture between Qidi Kefu and Sinochem's subsidiary. It focuses on fund investments in new materials, new energy, biotechnology, and other sectors. The firm has made 17 investments, including a Series E investment in New Radiomedicine on April 03, 2026.
General information
Firm type
Private Equity
Year founded
2020
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Frequently asked questions
Who runs investment decisions at Zhongqi Capital?
Public records and the firm's own website do not disclose named principals, investment committee members, or key decision-makers. This absence of identifiable leadership is unusual for a firm soliciting external capital and may reflect a domestic-only LP base that does not require the transparency standards associated with international institutional fundraising.
Does Zhongqi Capital participate in fund commitments or only direct deals?
The firm's stated strategy includes direct investments across seed, start-up, and expansion stages. No public record indicates participation in fund-of-funds commitments, LP stakes in third-party vehicles, or secondary market activity. The absence of regulatory filings or LP disclosures makes the precise investment structure difficult to verify from outside China.
What investment stages does Zhongqi Capital typically target?
Per the firm's own classification of its strategy, Zhongqi targets early-stage venture — including seed and start-up rounds — as well as growth and late-stage expansion deals. This full-spectrum approach is characteristic of Chinese PE firms that combine venture capital and growth equity under a single mandate.
Which sectors does Zhongqi Capital explicitly avoid?
The firm has not publicly disclosed sector exclusions or negative screens. Without visibility into the portfolio, sector concentrations, or investment committee commentary, there is no basis to identify sectors the firm avoids. In the Chinese regulatory environment, sectors subject to heightened state scrutiny — such as for-profit education and certain consumer internet verticals — have become de facto no-go zones for many domestic PE firms.
Where does Zhongqi Capital's capital come from?
The firm's LP base is not publicly disclosed. Beijing-based private equity firms of this profile typically raise capital from domestic high-net-worth individuals, family offices, and state-affiliated entities. The absence of international LP reporting obligations suggests Zhongqi does not currently manage capital from US or European institutional investors.
Does Zhongqi Capital maintain any philanthropic structures?
No philanthropic foundation, donor-advised fund, or charitable vehicle associated with Zhongqi Capital or its principals has been identified through public records. The firm makes no mention of impact investing, ESG mandates, or philanthropic activity in its limited public materials.
What is Zhongqi Capital's known posture on co-investments alongside external GPs?
The firm has not publicly articulated a co-investment policy. No instances of Zhongqi participating in club deals, syndicated rounds alongside named external GPs, or co-investment platforms have been documented in public records. The firm's low disclosure profile makes it impossible to verify whether co-investment activity exists.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: